Zoetis(US:ZTS) ZACKS·2025-11-04 14:11分组1 - Zoetis reported quarterly earnings of $1.7 per share, exceeding the Zacks Consensus Estimate of $1.62 per share, and showing an increase from $1.58 per share a year ago, resulting in an earnings surprise of +4.94% [1] - The company posted revenues of $2.4 billion for the quarter ended September 2025, slightly missing the Zacks Consensus Estimate by 0.35%, but showing a year-over-year increase from $2.39 billion [2] - Over the last four quarters, Zoetis has surpassed consensus EPS estimates four times and topped consensus revenue estimates three times [2] 分组2 - The stock has underperformed the market, losing about 11.4% since the beginning of the year, while the S&P 500 has gained 16.5% [3] - The company's earnings outlook, including current consensus earnings expectations for upcoming quarters, will be crucial for future stock performance [4] - The current consensus EPS estimate for the coming quarter is $1.48 on revenues of $2.42 billion, and for the current fiscal year, it is $6.35 on revenues of $9.5 billion [7] 分组3 - The Zacks Industry Rank indicates that the Medical - Drugs sector is currently in the top 36% of over 250 Zacks industries, suggesting that stocks in the top 50% outperform those in the bottom 50% by more than 2 to 1 [8] - The estimate revisions trend for Zoetis was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6]